Fora Capital, LLC Rapt Therapeutics, Inc. Transaction History
Fora Capital, LLC
- $903 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$18.1 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$10.6 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$10.6 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$10.1 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$9.53 Million0.24% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $24M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...